| Bioactivity | 6-Bromopravadoline (WIN 54461) is a CB1 antagonist. 6-Bromopravadoline acts as an inhibitor of the binding of [3H]Win 55212-2 (IC50=515 nM) reflective of cannabinoid receptor binding[1][2]. | ||||||||||||
| Target | CB1 | ||||||||||||
| Name | 6-Bromopravadoline | ||||||||||||
| CAS | 166599-63-9 | ||||||||||||
| Formula | C23H25BrN2O3 | ||||||||||||
| Molar Mass | 457.36 | ||||||||||||
| Appearance | Solid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Moloney GP, et al. Synthesis and cannabinoid activity of 1-substituted-indole-3-oxadiazole derivatives: novel agonists for the CB1 receptor. Eur J Med Chem. 2008;43(3):513-539. [2]. Eissenstat MA, Bell MR, D'Ambra TE, et al. Aminoalkylindoles: structure-activity relationships of novel cannabinoid mimetics. J Med Chem. 1995;38(16):3094-3105. |
6-Bromopravadoline
CAS: 166599-63-9 F: C23H25BrN2O3 W: 457.36
6-Bromopravadoline (WIN 54461) is a CB1 antagonist. 6-Bromopravadoline acts as an inhibitor of the binding of Win 55212-
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.